Ubiquinol Reduces Muscle Wasting but Not Fatigue in Tumor-Bearing Mice

Biological Research for Nursing

Volumn 17, Issue 3, 2015, Pages 321-329

  Clark, Yvonne Y ^a   Wold, Loren E ^b   Szalacha, Laura A ^b   McCarthy, Donna O ^c  

^a Pain Evaluation and Management Center of Ohio   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

cancer related fatigue; colon26 adenocarcinoma; mice; oxidative stress; tumor growth; ubiquinol

Indexed keywords

ANTIOXIDANT; UBIQUINOL; UBIQUINONE;

ADENOCARCINOMA; ANALOGS AND DERIVATIVES; ANIMAL; COLON TUMOR; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; FATIGUE; FEMALE; MOTOR ACTIVITY; MOUSE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADENOCARCINOMA; ANIMALS; ANTIOXIDANTS; COLONIC NEOPLASMS; FATIGUE; FEMALE; MICE; MOTOR ACTIVITY; MUSCLE, SKELETAL; NEOPLASMS, EXPERIMENTAL; OXIDATIVE STRESS; UBIQUINONE;

EID: 84930403091     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800414543822     Document Type: Article

References (55)

1. Amir Z.,Wilson K.,Hennings J.,Young A.The meaning of cancer: Implications for family finances and consequent impact on lifestyle, activities, roles and relationships.Psycho-Oncology. 2012;21:1167-1174
2. Barsevik A.,Frost M.,Zwinderman A.,Hall P.,Halyard M.I’m so tired: Biological and genetic mechanisms of cancer-related fatigue.Quality of Life Research. 2010;19:1419-1427
3. Bellot G.,Garcia-Medina R.,Gounon P.,Chiche J.,Roux D.,Pouyssegur J.,Mazure N.Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains.Molecular Cell Biology. 2009;29:2570-2581
4. Berger A. M.,Abernethy A. P.,Atkinson A.,Barsevick A. M.,Breitbart W. S.,Cella D.,Wagner L. I.Cancer-related fatigue.Journal of the National Comprehensive Cancer Network. 2010;8:904-931
5. Cobanoglu U.,Demir H.,Cebi A.,Sayir F.,Alp H. H.,Akan Z.,Bakan E.Lipid peroxidation, DNA damage and coenzyme q10 in lung cancer patients—markers for risk assessment?.Asian Pacific Journal of Cancer Prevention. 2011;12:1399-1403
6. Cosper P. F.,Leinwand L. A.Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.Cancer Research. 2011;71:1710-1720
7. Curigliano G.,Cardinale D.,Suter T.,Plataniotis G.,de Azambuja E.,Sandri M. T.,Roila F.Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines.Annals of Oncology. 2010;23:vii155-vii166
8. Dantzer R.,Meagher M. W.,Cleeland C. S.Translational approaches to treatment-induced symptoms in cancer patients.Nature Reviews Clinical Oncology. 2013;9:414-426
9. Dodson S.,Baracos V. E.,Jatoi A.,Evans W. J.,Cella D.,Dalton J. T.,Steiner M. S.Muscle wasting in cancer cachexia: Clinical implications, diagnosis and emerging treatment strategies.Annual Review of Medicine. 2011;62:265-279
10. D’Orlando C.,Marzetti E.,Francois S.,Lorenzi M.,Conti V.,di Stasio E.,Bossola M.Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle.Muscle Nerve. 2014;49:528-533
11. El-Sheikh A. A.,Morsy M. A.,Mahmoud M. M.,Rifaai R. A.,Abdelrahman A. M.Effect of coenzyme-Q10 on doxorubicin-induced nephrotoxicity in rats.Advances in Pharmacological Sciences, 2012. 2012;:
12. Fearon K.,Glass D. J.,Guttridge D. C.Cancer cachexia: Mediators, signaling, and metabolic pathways.Cell Metabolism. 2012;16:153-166
13. Foletta V. C.,White L. J.,Larsen A. E.,Leger B.,Russell A. P.The role and regulation of MAFbx/atrogen-1 and MuRF1 in skeletal muscle atrophy.Pflügers Archiv: European Journal of Physiology. 2011;461:325-335
14. Fouad A. A.,Al-Sultan A.,Refaie S. M.,Yacoubi M. T.Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice.Toxicology. 2010;274:49-56
15. Gilliam L.,St. Clair D. K.Chemotherapy-induced weakness and fatigue in skeletal muscle: The role of oxidative stress.Antioxidants & Redox Signaling. 2011;15:2543-2563
16. Graves E.,Ramsay E.,McCarthy D. O.Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma.Research in Nursing and Health. 2006;29:87-97
17. Haroon E.,Raison C. L.,Miller A. H.Psychoneuroimmunology meets neuropsychopharmacology: Translational implications for the impact of inflammation on behavior.Neuropsychopharmacology Reviews. 2012;37:137-162
18. Isfort M.,Stevens S. C.,Shaffer S.,Jong C. J.,Wold L. E.Metabolic dysfunction in diabetic cardiomyopathy.Heart Failure Reviews. 2014;19:35-48
19. Liu L.,Mills P. J.,Rissling M.,Florentino L.,Natarajan L.,Dimsdale J. E.,Ancoli-Israel S.Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.Brain, Behavior and Immunity. 2012;26:706-713
20. Mantovani G.,Madeddu C.,Maccio A.Cachexia and oxidative stress: An innovative therapeutic management.Current Pharmaceutical Design. 2012;18:4813-4818
21. Marin-Corral J.,Fontes C. C.,Pascual-Guardia S.,Sanchez F.,Olivan M.,Argiles J. M.,Barriero E.Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats.Antioxidants & Redox Signaling. 2010;12:365-380
22. Martin L.,Birdsell L.,Macdonald N.,Reiman T.,Clandinin M. T.,McCargar L. J.Cancer cachexia in tht age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.Journal of Clinical Oncology. 2013;31:1539-1547
23. Mazevet M.,Moulin M.,Llach-Martinez A.,Chargari C.,Deutsch E.,Gomez A.,Morel E.Complications of chemotherapy, a basic science update.Presse Medicale. 2013;42:e352-e361
24. Minton O.,Berger A.,Barsevick A.,Cramp F.,Goedendorp M.,Mitchell S. A.,Stone P. C.Cancer-related fatigue and its impact on functioning.Cancer. 2013;119:2124-2130
25. Muhlfeld C.,Das S. K.,Heinzel F. R.,Schmidt A.,Post H.,Schauer S.,Hoefler G.Cancer induced cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart.PLoS ONE. 2011;6:1-11
26. Munir F.,Yarker J.,McDermott H.Employment and the common cancers: Correlates of work ability during or following cancer treatment.Occupational Medicine. 2009;59:381-389
27. Murphy K. T.,Chee A.,Trieu J.,Naim T.,Lynch G. S.Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.Disease Models & Mechanisms. 2012;5:533-545
28. Murphy K. T.,Chee A.,Trieu J.,Naim T.,Lynch G. S.Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.International Journal of Cancer. 2013;133:1234-1246
29. Okayama T.,Kokura S.,Ishikawa T.,Adachi S.,Hattori T.,Takagi T.Antitumor effect of pretreatment for colon cancer cells with hyperthermia plus geranylgeranlacetone in experimental metastasis models and a subcutaneous tumor model of colon cancer in mice.International Journal of Hyperthermia. 2009;25:141-149
30. Owen J. B.,Butterfield D. A.Measurement of oxidized/reduced glutathione ratio.Methods of Molecular Biology. 2010;648:169-277
31. Palus D.,Akashi Y.,von Haehling S.,Anker S. D.,Springer J.The influence of age and sex on disease development in a novel animal model of cardiac cachexia.International Journal of Cardiology. 2009;133:388-392
32. Pertl M. M.,Hevey D.,Boyle N. T.,Hughes M. M.,Collier S.,O’Dwyer A. M.C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.Brain, Behavior, and Immunity. 2013;34:109-119
33. Rahman I.,Kode A.,Biswas S. K.Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method.Nature Protocols. 2006;1:3159-3165
34. Redon C. E.,Dickey J. S.,Nakamura A. J.,Kareva I. G.,Naf D.,Nowsheen S.Tumors induce complex DNA damage in distant proliferative tissues in vivo.Proceedings of the National Academy of Science (USA). 2010;107:17992-17997
35. Reid M. B.,Moylan J. S.Beyond atrophy: Redox mechanisms of muscle dysfunction in chronic inflammatory disease.Journal of Physiology. 2011;589:2171-2179
36. Rusciani L.,Proietti I.,Rusciani A.,Paradisi A.,Sbordoni G.,Alfano C.,Lippa S.Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression.Journal of the American Academy of Dermatology. 2006;54:234-241
37. Saligan L. N.,Kim H. S.A systematic review of the association between immunogenomic markers and cancer-related fatigue.Brain, Behavior, and Immunity. 2012;26:830-848
38. Sandri M.Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome.International Journal of Biochemistry & Cell Biology. 2013;45:2121-2129
39. Schmelzer C.,Kubo H.,Mori M.,Sawashita J.,Kitano M.,Hosoe K.Treatment with the reduced form of coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-α gene expression signature in SAMP1 mice.Molecular Nutrition & Food Research. 2010;54:805-815
40. Shadfar S.,Couch M. E.,McKinney K. A.,Weinstein L. J.,Yin X.,Rodriguez J. E.,Willis M.Oral Resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo.Nutrition and Cancer. 2011;63:749-762
41. Silverman M. N.,Heim C. M.,Nater U. M.,Marques A. H.,Sternberg E. M.Neuroendocrine and immune contributors to fatigue.PM & R. 2010;2:338-346
42. Sun Y. S.,Ye Z. Y.,Qian Z. Y.,Xu X. D.,Hu J. F.Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients.Journal of Experimental & Clinical Cancer Research. 2012;31:81
43. Suzuki J.,Asakawa A.,Amitani H.,Nakamura N.,Inui A.Cancer cachexia: Pathophysiology and management.Journal of Gastroenterology. 2013;48:574-594
44. Tian M.,Asp M. L.,Nishijima Y.,Belury M. A.Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.International Journal of Oncology. 2011;39:1321-1326
45. Tian M.,Nishijima Y.,Asp M. L.,Stout M. B.,Reiser P. J.,Belury M. A.Cardiac alterations in cancer-induced cachexia in mice.International Journal of Oncology. 2010;37:347-353
46. Tournoux F.,Petersen B.,Thibault H.,Zou L.,Raher M. J.,Kurtz B.,Scherrer-Crosbie M.Validation of noninvasive measurements of cardiac output in mice using echocardiography.Journal of the American Society of Echocardiography. 2011;24:465-470
47. van Hall G.Cytokines: Muscle protein and amino acid metabolism.Current Opinion in Clinical Nutrition & Metabolic Care. 2012;15:85-91
48. Wang X. S.,Williams L. A.,Krishnan S.,Liao Z.,Liu P.,Mao L. M.,Cleeland C. S.Serum sTNFR1, IL6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.Brain, Behavior, and Immunity. 2012;26:699-705
49. Weber M. A.,Krakowski-Roosen H.,Schroder L.,Kinscherf R.,Krix M.,Kopp-Schneider A.Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia.Acta Oncology. 2009;48:116-124
50. Wood L. J.,Nail L. M.,Gilster A.,Winters K. A.,Elsea C. R.Cancer chemotherapy-related symptoms: Evidence to suggest a role of proinflammatory cytokines.Oncology Nursing Forum. 2006;33:535-542
51. Wood L. J.,Weymann K.Inflammation and neural signaling: Etiologic mechanisms of the cancer treatment-related symptom cluster.Current Opinion in Supportive and Palliative Care. 2013;7:54-59
52. Wysong A.,Couch M.,Shadfar S.,Li L.,Rodriguez J. E.,Asher S.,Willis M. S.NF-kB inhibition protects against tumor-induced cardiac atrophy in vivo.American Journal of Pathology. 2011;178:1059-1068
53. Xu H.,Crawford D.,Hutchinson K. R.,Youtz D. J.,Lucchesi P. A.,Velten M.,Wold L. E.Myocardial dysfunction in an animal model of cancer cachexia.Life Sciences. 2011;88:406-410
54. Yang M.,Kim J.,Kim J.-S.,Kim S.-H.,Kim J.-C.,Kang M.-J.Hippocampal dysfunction in tumor-bearing mice.Brain, Behavior, and Immunity. 2014;36:147-155
55. Zombeck J. A.,Fey E. G.,Lyng G. D.,Sonis S. T.A clinically translatable mouse model for chemotherapy-related fatigue.Comparative Medicine. 2013;63:491-497